Literature DB >> 1693702

Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus.

W P Posthumus1, J A Lenstra, W M Schaaper, A P van Nieuwstadt, L Enjuanes, R H Meloen.   

Abstract

The amino acid sequences recognized by monoclonal antibodies (MAbs) specific for the antigenic site IV of the spike protein S of transmissible gastroenteritis virus were analyzed by PEPSCAN. All MAbs of group IV recognized peptides from the S region consisting of residues 378 to 390. In addition, the neutralizing MAbs (subgroup IV-A) also bound to peptides from the region consisting of residues 1173 to 1184 and to several other peptides with a related amino acid composition. The contribution of the individual residues of both sequences to the binding of a MAb was determined by varying the length of the peptide and by a consecutive deletion or replacement of parental residues by the 19 other amino acids. The sequence consisting of residues 326 to 558, tested as part of a cro-beta-galactosidase hybrid protein, was antigenic, but the sequence consisting of residues 1150 to 1239 was not. Furthermore, antibodies raised in rabbits against the peptide SDSSFFSYGEIPFGN (residues 377 to 391), but not those raised against the peptide VRASRQLAKDKVNEC (residues 1171 to 1185), recognized the virus and had neutralizing activity. We infer that the epitope of the neutralizing MAbs is composite and consists of the linear sequence SFFSYGEI (residues 380 to 387) with contributions of A, D, K, N, Q, or V residues from other parts of the S molecule. The complex epitope was simulated by synthesizing peptides in which the sequences consisting of residues 380 to 387 and 1176 to 1184 were combined. MAbs of subgroup IV-A recognized the combination peptides two to six times better than the individual sequences. These results may offer prospects for the development of an experimental vaccine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693702      PMCID: PMC249563     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.

Authors:  R H Meloen; W C Puyk; D J Meijer; H Lankhof; W P Posthumus; W M Schaaper
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

Review 2.  The antigenic structure of poliovirus.

Authors:  J M Hogle; D J Filman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1989-06-12       Impact factor: 6.237

3.  Analysis of an immunodominant region of infectious bronchitis virus.

Authors:  J G Kusters; E J Jager; J A Lenstra; G Koch; W P Posthumus; R H Meloen; B A van der Zeijst
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

4.  Identification of epitopes of immunological importance on the peplomer of porcine transmissible gastroenteritis virus.

Authors:  D J Garwes; F Stewart; C J Elleman
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

5.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

6.  The predicted primary structure of the peplomer protein E2 of the porcine coronavirus transmissible gastroenteritis virus.

Authors:  D Rasschaert; H Laude
Journal:  J Gen Virol       Date:  1987-07       Impact factor: 3.891

7.  Antigenic structure of transmissible gastroenteritis virus. I. Properties of monoclonal antibodies directed against virion proteins.

Authors:  H Laude; J M Chapsal; J Gelfi; S Labiau; J Grosclaude
Journal:  J Gen Virol       Date:  1986-01       Impact factor: 3.891

8.  The nucleotide sequence of the peplomer gene of porcine transmissible gastroenteritis virus (TGEV): comparison with the sequence of the peplomer protein of feline infectious peritonitis virus (FIPV).

Authors:  L Jacobs; R de Groot; B A van der Zeijst; M C Horzinek; W Spaan
Journal:  Virus Res       Date:  1987-11       Impact factor: 3.303

9.  Antigenicity of the peplomer protein of infectious bronchitis virus.

Authors:  J A Lenstra; J G Kusters; G Koch; B A van der Zeijst
Journal:  Mol Immunol       Date:  1989-01       Impact factor: 4.407

10.  Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus.

Authors:  I Correa; G Jiménez; C Suñé; M J Bullido; L Enjuanes
Journal:  Virus Res       Date:  1988-04       Impact factor: 3.303

View more
  23 in total

1.  Altering the antigenicity of proteins.

Authors:  H Alexander; S Alexander; E D Getzoff; J A Tainer; H M Geysen; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

2.  Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus.

Authors:  M Godet; D Rasschaert; H Laude
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

3.  Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.

Authors:  Hong Zhang; Guangwen Wang; Jian Li; Yuchun Nie; Xuanling Shi; Gewei Lian; Wei Wang; Xiaolei Yin; Yang Zhao; Xiuxia Qu; Mingxiao Ding; Hongkui Deng
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1.

Authors:  J P Langedijk; N K Back; E Kinney-Thomas; C Bruck; M Francotte; J Goudsmit; R H Meloen
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirus.

Authors:  T Tuboly; E Nagy; J R Dennis; J B Derbyshire
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Polymeric display of immunogenic epitopes from herpes simplex virus and transmissible gastroenteritis virus surface proteins on an enteroadherent fimbria.

Authors:  D B Rani; M E Bayer; D M Schifferli
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

7.  Immunogenicity of eGFP-Marked Recombinant Lactobacillus casei against Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus.

Authors:  Meiling Yu; Li Wang; Sunting Ma; Xiaona Wang; Yusai Wang; Ya Xiao; Yanping Jiang; Xinyuan Qiao; Lijie Tang; Yigang Xu; Yijing Li
Journal:  Viruses       Date:  2017-09-25       Impact factor: 5.048

8.  Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis.

Authors:  Sariqa Wagley; Monika Bokori-Brown; Helen Morcrette; Andrea Malaspina; Caroline D'Arcy; Sharmilee Gnanapavan; Nicholas Lewis; Michel R Popoff; Dominika Raciborska; Richard Nicholas; Ben Turner; Richard W Titball
Journal:  Mult Scler       Date:  2018-04-21       Impact factor: 6.312

9.  Carbohydrate-induced conformational changes strongly modulate the antigenicity of coronavirus TGEV glycoproteins S and M.

Authors:  B Delmas; H Laude
Journal:  Virus Res       Date:  1991-07       Impact factor: 3.303

10.  Antigen selection and presentation to protect against transmissible gastroenteritis coronavirus.

Authors:  L Enjuanes; C Suñé; F Gebauer; C Smerdou; A Camacho; I M Antón; S González; A Talamillo; A Méndez; M L Ballesteros
Journal:  Vet Microbiol       Date:  1992-11       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.